COMMUNIQUÉS West-GlobeNewswire

Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
24/04/2026
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its first [...]
Geneva College of Longevity Science Launches the World’s First PhD in Longevity Sciences
24/04/2026
GENEVA and CONSTANȚA, Romania, April 24, 2026 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) today announced the launch of the world’s first PhD in Medicine with a specialization in Longevity [...]
Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
24/04/2026
SANDWICH, United Kingdom, April 24, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), will today present positive [...]
Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program
24/04/2026
Cambridge, UK, 24 th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the presentation of new [...]
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24/04/2026
Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment gap WHO prequalification key milestone for donor-funded and public sector [...]
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
24/04/2026
“Totality of evidence” approach to evaluate SCENESSE® EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo study EMA emphasised its “totality of evidence” approach central [...]
Vistin Pharma ASA: First quarter 2026 financial results
24/04/2026
Vistin Pharma ASA: First quarter 2026 financial results Oslo, Norway, 24 th of April 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2026. First quarter revenue of MNOK 112 [...]
The top 250 cancer specialists converge in Belgium to push the frontiers of proton therapy
24/04/2026
IBA gathers the most knowledgeable proton therapy experts coming from the most prestigious cancer care institutions. Louvain-La-Neuve, Belgium, April 24, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world [...]
Les 250 meilleurs spécialistes du cancer se réunissent en Belgique pour repousser les frontières de la protonthérapie
24/04/2026
IBA réunit les experts les plus renommés en protonthérapie venant des institutions de soins oncologiques les plus prestigieuses. Louvain-la-Neuve, Belgique, le 24 avril 2026 – IBA (Ion Beam Applications S.A., EURONEXT [...]
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24/04/2026
Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment gap WHO prequalification key milestone for donor-funded and public sector [...]
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
24/04/2026
Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing loss White Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and [...]
Denta Biome Under Investigation: Adem Naturals Chewable Dental Tablets for Oral Health Care Support
23/04/2026
A 2026 informational overview of Denta Biome chewable dental tablets, oral postbiotic science, FabM enzyme research context, gum health and bad breath ingredient analysis, pricing structure, and consumer verification [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23/04/2026
WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
24/04/2026
-- Cash and Cash Investments at December 31, 2025 of €116.5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected to Extend Cash Runway into First Half of 2029 -- -- Positive [...]
AVITA Medical to Announce First Quarter 2026 Financial Results
23/04/2026
VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial [...]
Chemed Reports First-Quarter 2026 Results
23/04/2026
Full-Year Guidance Increased Due To: Strong VITAS Performance Re-purchase of 500,000 Shares in the Quarter Two Roto-Rooter Franchises Purchased for $20.6 Million CINCINNATI, April 23, 2026 (GLOBE NEWSWIRE) -- Chemed [...]
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
24/04/2026
WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial results. Full Year 2025 [...]
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
23/04/2026
SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the [...]
Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
23/04/2026
Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a [...]

Pages